Even though they are not the dominant source of cytokines in circulation, these findings indicate that IL-17A production by γδ T cells best represents the inflammatory status of liver inflammation measurable in blood and has the potential to be a reliable non-invasive biomarker for NASH in humans. Here, IL17A is linked to metabolic dysfunction-associated steatohepatitis.